Dr. Jen Chin Wang, MD

Dr. Wang practices at Port Jefferson Station Medical Oncology in Ridge, New York.

Dr. Wang's NPI, 1205938115, was assigned on September 1, 2006. Dr. Wang graduated from National Taiwan University College of Medicine in 1969. Dr. Wang holds New York license 121901.

Dr. Wang's primary practice is Port Jefferson Station Medical Oncology, at 1 Research Rd, Ridge, NY 11961. The practice phone is (631) 751-3000.

Dr. Wang's primary practice is Port Jefferson Station Medical Oncology in Ridge, New York. Dr. Wang is also affiliated with Brookdale Hospital Medical Center. The medical group on file is New York Cancer & Blood Specialists. Dmand AI also links Dr. Wang to 3 more medical groups and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Wang practices, 3 sites in all. Vendor and product names are available with a free account.

Hematology and oncology is Dr. Wang's primary specialty in the NPI Registry, under taxonomy code 207RH0003X. Dr. Wang is licensed in New York.

CMS data shows 10,599 Medicare services from Dr. Wang across 7 procedure codes in 2024, for 106 Medicare patients. Medicare paid $41,824 for them. Every service was in an office.

CMS counts 106 Medicare patients who saw Dr. Wang in 2024. The largest group is 65 to 74, with 42 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 27% are also on Medicaid. Their average risk score is 1.59, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Wang's median patient age at 57, with 59% women.

In 2024, Dr. Wang wrote 976 Medicare Part D claims for 101 patients. 36% of them were for generic drugs. CMS names the drug for 741 of them, across 33 drugs with 11 or more claims each, at $6,187,245 in total drug cost. In 2023, CMS named 728 claims across 28 drugs.

Dr. Wang accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links Dr. Wang to 1 clinical trial. Open Payments lists research payments to Dr. Wang that name 1 trial.

CMS Open Payments shows 1,054 general payments to Dr. Wang from 65 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 77% of the total. Celgene Corporation paid the most, $7,496. It also lists 2 research payments totaling $9,438 in 2017, naming 1 clinical trial.

Dr. Wang graduated from National Taiwan University College of Medicine in 1969.